Fuji, Japan

Kazuyoshi Hori

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Asahi Kasei Kogyo Kabushiki Kaisha, Health Research, Inc.. Active years: 1993-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuyoshi Hori. Retrieved from https://idiyas.com/inventor/kazuyoshi-hori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 50(Granted Patents)


Location History:

  • Fuji, JP (1993 - 1994)
  • Hori, JP (1995)

Company Filing History:


Years Active: 1993-1995

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazuyoshi Hori: Innovator in Osteoporosis Treatment

Introduction

Kazuyoshi Hori is a notable inventor based in Tokyo, Japan. He is currently associated with Asahi Kasei Pharma Corporation, where he focuses on developing innovative solutions in the pharmaceutical field. Although he has not yet been granted any patents, his work is significant in the area of osteoporosis treatment.

Latest Patent Applications

Kazuyoshi Hori's latest patent application is titled "PTH-Containing Therapeutic/Prophylactic Agent for Osteoporosis, Characterized in That PTH is Administered Once a Week in a Unit Dose of 100 to 200 Units." The objective of this application is to provide a method of treating osteoporosis using PTH that demonstrates excellent safety and high efficacy. Additionally, it aims to inhibit or prevent bone fractures through the administration of PTH, which is characterized by a unit dose of 100 to 200 units administered weekly.

Conclusion

Kazuyoshi Hori's contributions to the field of osteoporosis treatment highlight his commitment to innovation in pharmaceuticals. His ongoing research and patent applications reflect his dedication to improving patient outcomes in this critical area of health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…